A patient with history of increased lethargy and significant loss of weight found to have elevated carcinoembryonic antigens (CEA) in laboratory examination. He may have all of the following conditions, EXCEPT:
**Core Concept**
The patient's elevated carcinoembryonic antigen (CEA) levels and symptoms of lethargy and weight loss suggest a possible diagnosis of cancer. CEA is a tumor marker commonly associated with adenocarcinomas, particularly colorectal cancer.
**Why the Correct Answer is Right**
The elevated CEA levels in this patient are likely indicative of a malignancy, possibly colorectal cancer. The patient's symptoms of lethargy and weight loss are non-specific but can be associated with advanced cancer. The pathophysiology of cancer involves uncontrolled cell growth, invasion, and metastasis, leading to various systemic symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** Colorectal cancer is a correct association with elevated CEA levels. This is a common malignancy associated with this tumor marker.
**Option B:** Gastric cancer can also be associated with elevated CEA levels, although it is less common than colorectal cancer.
**Option D:** Pancreatic cancer is another malignancy that can be associated with elevated CEA levels, although it is not as specific as it is for colorectal cancer.
**Why Each Wrong Option is Incorrect (continued)**
**Option C:** Small cell lung cancer (SCLC) is a type of lung cancer that is typically associated with elevated neuron-specific enolase (NSE) levels, not CEA. This is a key distinction in tumor markers for different types of cancer.
**Clinical Pearl / High-Yield Fact**
Remember that tumor markers like CEA are not specific for a particular cancer type and can be elevated in various conditions, including benign diseases and other malignancies. A high index of suspicion and clinical correlation are essential for interpreting tumor marker results.
**Correct Answer: C. Small cell lung cancer. Small cell lung cancer.**